flumazenil has been researched along with ncs 382 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gobaille, S; Maitre, M; Pain, L; Sandner, G; Schmidt-Mutter, C | 1 |
| Carai, MA; Colombo, G; Gessa, GL | 1 |
| Carter, LP; Coop, A; France, CP; Koek, W; Wu, H | 1 |
3 other study(ies) available for flumazenil and ncs 382
| Article | Year |
|---|---|
The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzocycloheptenes; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; Male; Motor Activity; Naloxone; Narcotic Antagonists; Rats; Sodium Oxybate | 1998 |
Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice.
Topics: Animals; Benzocycloheptenes; Bicuculline; Drug Overdose; Flumazenil; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Morpholines; Naltrexone; Neuroprotective Agents; Neurotransmitter Agents; Survival Rate; Taurine | 2005 |
Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
Topics: 4-Butyrolactone; Animals; Baclofen; Benzocycloheptenes; Butylene Glycols; Columbidae; Discrimination, Psychological; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Organophosphorus Compounds; Sodium Oxybate | 2006 |